Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Chemistry World March 22, 2009 Sarah Houlton	Integrin inhibitors could promote tumour growth A group of scientists has found that at low doses these drugs might actually have the opposite effect and promote tumor growth.
Chemistry World June 11, 2007 Victoria Gill	Cancer Therapy Targets Bad Blood Tumors have a nasty habit of quickly developing their own blood supply in order to feed their rapid growth. Now, researchers have discovered a set of biological markers that distinguish tumor-specific blood vessels from normal, healthy vasculature.
Chemistry World September 10, 2008 Simon Hadlington	Failed anxiety drug could treat cancer Scientists believe they have solved the mystery of how a drug originally developed for treating anxiety can kill cancer cells.
Chemistry World October 8, 2007 James Mitchell Crow	MRI Sensitivity Boosted by 10000 Times A technique that significantly boosts the sensitivity of magnetic resonance imaging is on the verge of clinical trials which, if successful, could allow doctors to assess the effects of cancer drugs on a tumor within hours.
Chemistry World July 3, 2015 Andy Extance	Pharma queues up for checkpoint inhibitor collaborations Amid fierce rivalries over the latest generation of cancer treatments, drug makers have been weaving a complex web of collaborations on combination therapies spanning much of the pharmaceutical industry.
Chemistry World May 4, 2006 Katharine Sanderson	Cancer Charity Takes on Shelved Drugs Cancer Research UK, and its commercial arm, Cancer Research Technology have launched a clinical development partnership scheme to sweep up drug candidates that pharmaceuticals companies have deprioritized for not showing enough commercial promise.
The Motley Fool June 17, 2010 Luke Timmerman	Oncothyreon's Cancer Vaccine Back in the Saddle as Merck KGaA Re-Starts Clinical Trials The German-based Merck got clearance from the FDA and local ethics review boards to resume two of three large pivotal trials.
Bio-IT World September 2005 Kevin Davies	Bringing Good Things to Informatics In interview with Nick Giannasi, Head of Informatics for GE Healthcare's Bio-Sciences division on how the company is shedding light on data integration in discovery and clinical trials.
Chemistry World March 4, 2011 Elinor Richards	Laser treatment for late-stage cancer Scientists from China, the US and Peru claim to have successfully treated late-stage breast cancer patients using laser immunotherapy to stimulate patients' own immune systems to fight the cancer.
Chemistry World June 12, 2014 Andy Extance	Pharma vies to unleash immune system power on cancer Drug firms are investing heavily in clinical trials and collaborations as they seek to capitalize on the potential of cancer therapies that enlist or enhance our immune systems' ability to fight tumors.
Pharmaceutical Executive July 1, 2011 Dickmeyer & Rosenbeck	From Rut to Racetrack Can the pharmaceutical industry deliver on its objective to make cancer a curable, chronic condition?
Chemistry World November 23, 2006 Victoria Gill	Bacteria That Help Fight Cancer Scientists have given a new meaning to the term `friendly bacteria' by discovering a bacterial protein that helps treat cancer.
Chemistry World April 2006 Karen Harries-Rees	Editorial: Drugs Testing on Trial A drugs trial in the UK that went disastrously wrong last month has raised questions about the ethics of using paid volunteers in clinical trials and the usefulness of animal testing.
Chemistry World July 2010 Anna Lewcock	Medicine made to measure Healthcare tailored to suit the genetic makeup of the patient is finally coming to fruition.
Scientific American March 2009 Elaine Schattner	A Chip against Cancer: Microfluidics Scrutinizes T Cells With just a blood sample, a device could determine whether cancer is about to spread or monitor the progress of treatment
Chemistry World August 21, 2008 Ananyo Bhattacharya	Human trials for dyes that make cancers glow An imaging system that makes cancers glow brightly under infrared light has entered human clinical trials, US researchers reported at the American Chemical Society's Fall 2008 meeting
Chemistry World July 28, 2006 Tom Westgate	Radioactive Scorpion Venom Stings Brain Tumours Scorpion venom carries a nasty sting for brain tumour cells. A peptide based on chlorotoxin, found in the venom of the Giant Yellow Israeli Scorpion, has been used to target glioma, a particularly aggressive form of brain tumour.
Chemistry World January 8, 2007 Michael Gross	Nano-Clots Target Tumours Researchers have created nanoparticles that form clots within the blood vessels of tumors. They hope that with further improvements these could be used either to starve tumors or to target them with cytotoxic drugs.
Chemistry World February 17, 2006 Katharine Sanderson	Designing liposomes to avoid chemotherapy side effects The side effects of a common chemotherapy agent, cisplatin, can be avoided if the molecule is encapsulated in a finely tuned liposome, claim Danish biophysicists.
Managed Care January 2004 Thomas Morrow	Choking Off a Tumor's Blood Supply Angiogenesis blockade is a 30-year-old concept, but it will soon make the leap from lab bench to pharmacy shelf.
Chemistry World July 25, 2008 Olivia Walker	Engineered antibodies could cut chemotherapy risks US scientists have cut the side-effects of cancer treatment in animal trials by carefully controlling the number of drug molecules attached to the antibodies used for chemotherapy.
Chemistry World January 17, 2008 Lewis Brindley	Nanomachines to Treat Cancer Scientists at the University of California-Los Angeles (UCLA) have signed a deal with a private investment firm to develop and market 'nanomachines' to treat cancer.
BusinessWeek July 15, 2010 Lopatto & Matsuyama	The Race for Diagnostic Tests for Alzheimer's GE, Bayer, and Avid are vying to be first to market an early test for Alzheimer's.
Chemistry World June 4, 2015 Thadchajini Retneswaran	Microfluidic approach to personalised cancer treatment US scientists have developed an innovative microfluidic assay that can accurately predict how patients with a certain type of blood cancer will respond to an anticancer drug.
BusinessWeek October 15, 2009	Healthy Business In May, GE launched the "Healthymagination" campaign to promote its growing medical division. Here are some vital statistics.
Chemistry World November 21, 2006 Victoria Gill	Side-Effect-Free Chemotherapy Scientists have now developed an enzyme with the potential to eliminate the extreme fatigue, sickness and hair loss that result from this cell damage and strike fear into the hearts of cancer patients.
Pharmaceutical Executive October 1, 2010	When the Payer IS the Player As Medicare, Medicaid, and the nation's web of private payers gain market power, how can pharma stay ahead of the cost-containment curve?
The Motley Fool April 28, 2009 Brian Orelli	Headline? Bad! Unexpected? No! For a company that only has one drug on the market, stopping a failing phase 3 clinical trial that's designed to expand the market of that drug is usually a major blow. But Onyx Pharmaceuticals was able to shrug it off.
Chemistry World May 28, 2008 Mark Peplow	Cancer research gets collaborative funding boost In an effort to crack some of the biggest problems in cancer drug discovery, Cancer Research UK has launched a unique funding program that promises to help bridge the gap between fundamental research and big pharma pipelines.
The Motley Fool October 27, 2006 Jack Uldrich	Nanotech and the War on Cancer New imaging advances in nanotechnology will help speed cancers' end. What does it mean for investors?
Pharmaceutical Executive October 1, 2011 William Looney	Curative Powers of Collaboration Napoleone Ferrara's career in medicine is an illustration of the maxim that stretching the boundaries of science is a leap in the dark.
Chemistry World February 11, 2011 David Barden	Waking up to new possibilities in imaging UK researchers have used a cage-like molecule to smuggle metal ions into cells, which could improve medical imaging.
Bio-IT World September 2005 Alan Louie	Molecular Imaging: Smarter and Better The expanding opportunity for molecular imaging (MI) technology to significantly improve drug development has not gone unobserved. Several drug development companies have added imaging capabilities to their arsenal of drug development tools.
The Motley Fool April 27, 2011 Brian Orelli	Falling Into the Zaltrap Lung cancer out, colon cancer in phase 3 clinical trial for Regeneron Pharmaceuticals' new drug.
Chemistry World July 2010 Hayley Birch	Special Report: Health breakthroughs of the decade New discoveries have been made with cancer vaccines, genomics, statin drugs, allosteric modulators, and RNA interference during the last decade.
Chemistry World July 22, 2013 Kirsty Muirhead	Circulating cancer cells spiral towards separation A new biochip developed by researchers in Singapore can isolate tumor cells from blood samples, and may one day be an alternative to more invasive methods for tracking later stage cancers.
Pharmaceutical Executive April 1, 2006 Joanna Breitstein	HBA Woman of the Year: Susan Desmond-Hellman There are people who hope cancer, one day, will become a manageable disease. Then there are those who know it. Meet Susan Desmond-Hellmann.
Pharmaceutical Executive July 1, 2012 Jill Wechsler	Who Will Pay for New Drugs? Comparative research documenting value and affordability is key to obtaining coverage for high-cost therapies.
The Motley Fool October 26, 2010 Ralph Casale	Where We Are in the War on Cancer A summary of the roundtable discussions at Xconomy's recent event, "Boston's War on Cancer."
Chemistry World October 16, 2007 Ned Stafford	Germany's 900m Euro Molecular Imaging Drive Five German companies and the Federal Ministry of Education and Research are to spend almost a billion euros in an effort to strengthen the nation's international competitiveness in molecular imaging, which will require a large dose of nanotechnology research.
Chemistry World June 4, 2008 John Bonner	Fireflies make light work of tumours Cancer researchers can see how effective new chemotherapy drugs are at destroying tumours by using the light that causes fireflies to glow in the dark.
Chemistry World January 13, 2015 Jennifer Newton	Infrared offers odds on skin cancer spreading Scientists in Belgium have shown that infrared spectrometry can help predict how likely it is that a melanoma tumor, the deadliest form of skin cancer, has spread to other organs.
BusinessWeek August 26, 2010 Tom Randall	Cocktails Are Next For Cancer-Drug Makers Taking a cue from the cocktails of drugs that have made AIDS survivable, drugmakers are pursuing combination therapies against cancer.
Chemistry World January 6, 2010 Ned Stafford	UK libel laws threaten scientific debate A libel lawsuit brought by GE Healthcare has succeeded in silencing an eminent Danish radiologist who questioned the safety of one of the firm's drugs, but the firm is now being accused by some in the scientific community of trying to stifle legitimate scientific discussion.
Pharmaceutical Executive February 1, 2013 William Looney	Pathways to Progress Cancer is increasingly understood as a collection of rare and mostly treatable conditions rather than the impregnable, monolith portrayed in popular culture. Industry experts review current and pending efforts to turn great science into good practice.
The Motley Fool April 13, 2004 Lita Epstein	GE Bets on Health Care Closing a $9.5 billion deal for the U.K.'s Amersham assures a major role for GE Healthcare.
The Motley Fool October 27, 2010 Ralph Casale	Companion Diagnostics in Cancer Drug Development Diagnostic companies partnering with drug developers can make for an attractive investment segment.
Chemistry World January 17, 2011 Laura Howes	Nanoparticle divides to conquer Scientists have made a nanoparticle that breaks up into smaller units once it reaches its target, allowing it to penetrate deeper into tumour tissue and deliver treatment more effectively.
Chemistry World June 20, 2011 Simon Hadlington	Chatty Nanoparticles Signal the Attack on Tumours Researchers in the US have shown how drugs can be directed to a tumour using two different nanoparticles that can talk to each other.
The Motley Fool November 2, 2004 Charly Travers	Biotech's 5-Baggers: Part 3 Year after year, the hottest biotech companies with investors are those with drugs in development for the treatment of cancer.